Evangelisches Waldkrankenhaus Spandau Krankenhausbetriebs gGmbH — Clinical Trial Site

11 Registered trials

7 Currently recruiting

Organisation

Evangelisches Waldkrankenhaus Spandau Krankenhausbetriebs gGmbH

Location

Berlin, Germany

Identifier

ORG-100026029

Address

Stadtrandstrasse 555-561/2, Spandau, 13589, Germany

Departments

Apotheke
Brustzentrum
Evangelisches Waldkrankenhaus Spandau, Brustzentrum
Gynaecology
Hämatologie und Onkologie
Innere Medizin 1 – Hämatologie/Onkologie
Klinik für Innere Medizin 1 Onkologisches Zentrum
Klinik für Orthopädie und Unfallchirurgie
Onkologisches Zentrum
Orthopädie und Traumatologie
Orthopädie und Unfallchirurgie

Clinical trials at this site (11)

Search interface

Phase I/IIa study to test the safety and efficacy of MSC from umbilical cord tissue (UC-MSC) for the treatment of cartilage damage in the kn… Recruiting

2024-517684-23-00 Cartilage defect of the knee joint 7 2025-10-23
Randomized, controlled, multi-center clinical trial for the treatment of osteoarthritis behind the kneecap with tissue engineered nasal cart… Recruiting

2024-513683-25-00 Patellofemoral osteoarthritis 4 2025-06-30
Pre-Operative Treatment in rEseCTable cOlon canceR (PROTECTOR/FIRE-10; AIO-KRK-0620; IAG-VO-0323) Prospective, randomized, open-label, multi… Recruiting

2023-508076-11-00 Colon cancer staged T3-4 and/or nodal positive by CT an 5 2025-04-01
ENhanced recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis after primary Hip Arthroplasty Recruiting

2023-507490-18-00 Patients undergoing elective unilateral primary hip art 5 2024-11-26
NeoAdjuvant study comparing sacituzumab govitecan versus sacituzumab govitecan+pembrolizumab treatment in low-risk, triple-negative early br… Recruiting

2023-508787-29-00 Triple-negative early breast cancer with low risk for r 4 2024-10-10
RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials (MMRd-GREEN) Recruiting

2023-503267-42-00 Patients with a histological diagnosis of mismatch- rep 5 2022-06-10
FOLFOX before surgey compared to risk-adapted chemotherapy after surgery in patients with locally advanced rectal cancer and low risk for lo… Recruiting

2024-518077-34-00 locally advanced rectal cancer 5 2020-09-30
NeoAdjuvant Dynamic marker - Adjusted Personalized Therapy comparing trastuzumab-deruxtecan versus pacli-/docetaxel+carboplatin+trastuzumab+… Ended

2024-514458-61-01 HER2+ early breast cancer 4 2024-02-05
Short course radiotherapy versus chemoradiotherapy, followed by consolidation chemotherapy, and selective organ preservation for MRI-defined… Ended

2024-511577-29-01 intermediate and high-risk rectal cancer 5 2020-03-13
Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate-risk… Ended

2024-515769-32-00 HR+/HER2- early breast cancer 5 2019-07-02
CIRCULATE Ended

2023-506715-18-00 colon cancer stage II, rectal cancer stage II 5 2019-12-04